TRVI logo

Trevi Therapeutics, Inc. (TRVI) Cash from operations

annual CFO:

-$38.26M-$6.55M(-20.64%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TRVI annual cash flow from operations is -$38.26 million, with the most recent change of -$6.55 million (-20.64%) on December 31, 2024.
  • During the last 3 years, TRVI annual CFO has fallen by -$9.31 million (-32.16%).
  • TRVI annual CFO is now -381.69% below its all-time high of -$7.94 million, reached on December 31, 2017.

Performance

TRVI Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

quarterly CFO:

-$10.10M+$3.38M(+25.05%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI quarterly cash flow from operations is -$10.10 million, with the most recent change of +$3.38 million (+25.05%) on June 30, 2025.
  • Over the past year, TRVI quarterly CFO has dropped by -$1.42 million (-16.33%).
  • TRVI quarterly CFO is now -146.61% below its all-time high of -$4.10 million, reached on March 31, 2019.

Performance

TRVI quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

TTM CFO:

-$42.68M-$1.42M(-3.44%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI TTM cash flow from operations is -$42.68 million, with the most recent change of -$1.42 million (-3.44%) on June 30, 2025.
  • Over the past year, TRVI TTM CFO has dropped by -$9.90 million (-30.18%).
  • TRVI TTM CFO is now -660.86% below its all-time high of -$5.61 million, reached on June 30, 2018.

Performance

TRVI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TRVI Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.6%-16.3%-30.2%
3 y3 years-32.2%-63.5%-59.6%
5 y5 years-65.7%-19.7%-57.8%

TRVI Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.8%at low-63.5%+25.1%-59.6%at low
5 y5-year-65.7%at low-63.5%+25.1%-62.4%at low
alltimeall time-381.7%at low-146.6%+25.1%-660.9%at low

TRVI Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$10.10M(-25.1%)
-$42.68M(+3.4%)
Mar 2025
-
-$13.48M(+41.1%)
-$41.27M(+7.9%)
Dec 2024
-$38.26M(+20.6%)
-$9.55M(-0.1%)
-$38.26M(+9.1%)
Sep 2024
-
-$9.56M(+10.1%)
-$35.06M(+6.9%)
Jun 2024
-
-$8.68M(-17.0%)
-$32.79M(-3.5%)
Mar 2024
-
-$10.47M(+64.6%)
-$33.98M(+7.2%)
Dec 2023
-$31.71M(+12.5%)
-$6.36M(-12.6%)
-$31.71M(+0.1%)
Sep 2023
-
-$7.28M(-26.3%)
-$31.68M(-3.9%)
Jun 2023
-
-$9.88M(+20.5%)
-$32.98M(+12.6%)
Mar 2023
-
-$8.20M(+29.5%)
-$29.28M(+3.9%)
Dec 2022
-$28.18M(-2.7%)
-$6.33M(-26.2%)
-$28.18M(+0.4%)
Sep 2022
-
-$8.58M(+38.9%)
-$28.07M(+5.0%)
Jun 2022
-
-$6.18M(-12.9%)
-$26.74M(-6.1%)
Mar 2022
-
-$7.09M(+13.9%)
-$28.46M(-1.7%)
Dec 2021
-$28.95M
-$6.23M(-14.0%)
-$28.95M(-8.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$7.24M(-8.3%)
-$31.64M(+0.9%)
Jun 2021
-
-$7.90M(+4.2%)
-$31.37M(-1.7%)
Mar 2021
-
-$7.58M(-15.1%)
-$31.91M(+10.0%)
Dec 2020
-$29.00M(+25.6%)
-$8.92M(+28.1%)
-$29.00M(+10.4%)
Sep 2020
-
-$6.97M(-17.4%)
-$26.28M(-2.8%)
Jun 2020
-
-$8.44M(+80.5%)
-$27.05M(+14.3%)
Mar 2020
-
-$4.67M(-24.7%)
-$23.67M(+2.5%)
Dec 2019
-$23.09M(+26.0%)
-$6.20M(-19.8%)
-$23.09M(+6.8%)
Sep 2019
-
-$7.73M(+52.8%)
-$21.62M(+55.7%)
Jun 2019
-
-$5.06M(+23.6%)
-$13.89M(-3.8%)
Mar 2019
-
-$4.10M(-13.4%)
-$14.44M(+39.6%)
Dec 2018
-$18.32M(+130.7%)
-$4.73M(-15.7%)
-$10.34M(+84.3%)
Jun 2018
-
-$5.61M
-$5.61M
Dec 2017
-$7.94M(-29.0%)
-
-
Dec 2016
-$11.19M
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual CFO year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly CFO year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM CFO year-on-year change?

What is Trevi Therapeutics, Inc. annual cash flow from operations?

The current annual CFO of TRVI is -$38.26M

What is the all time high annual CFO for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual cash flow from operations is -$7.94M

What is Trevi Therapeutics, Inc. annual CFO year-on-year change?

Over the past year, TRVI annual cash flow from operations has changed by -$6.55M (-20.64%)

What is Trevi Therapeutics, Inc. quarterly cash flow from operations?

The current quarterly CFO of TRVI is -$10.10M

What is the all time high quarterly CFO for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly cash flow from operations is -$4.10M

What is Trevi Therapeutics, Inc. quarterly CFO year-on-year change?

Over the past year, TRVI quarterly cash flow from operations has changed by -$1.42M (-16.33%)

What is Trevi Therapeutics, Inc. TTM cash flow from operations?

The current TTM CFO of TRVI is -$42.68M

What is the all time high TTM CFO for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM cash flow from operations is -$5.61M

What is Trevi Therapeutics, Inc. TTM CFO year-on-year change?

Over the past year, TRVI TTM cash flow from operations has changed by -$9.90M (-30.18%)
On this page